None listed
Conditions
Interventions
Intervention1: Multani Mitti (Fullers Earth) Face Pack: Test Product (T): Multani Mitti Face Pack. Standardized preparation: 20 grams of pure, cosmetic-grade Multani Mitti powder will be mixed with a
Sponsors
Central Council for Research in Unani Medicine (CCRUM), Ministry of Ayush, Government of India
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy male and female individuals between the age of 18 to 35 years. 2. Oily skin type confirmed at baseline using the blotting paper method, defined as a translucent oil spot of Grade 3 or More than Grade 3 on a 0-5 visual grading scale. 3. Individuals must show their willingness to provide written informed consent and comply with the study protocol which include a 1-week washout for every other facial topical treatment
Exclusion criteria
Exclusion criteria: 1. Known allergy to cosmetic products, clay or Niacinamide. 2. Active facial dermatoses (e.g., cystic acne, rosacea, atopic dermatitis). 3. Use of systemic or topical medications known to influence sebum production (e.g., oral/topical retinoids, hormonal agents) in the past 3 months. 4. Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary (Sebum Secretion): Standardized blotting paper technique. A standard blotting paper (e.g., 5 cm x 5 cm) will be pressed firmly onto the forehead on each side for 10 seconds. The resulting translucent oil spot will be immediately graded by the blinded assessor against a validated 5-point visual scale (0=No spot, 1=Faint spot, 2=Moderate spot, 3=Large, distinct spot, 4=Saturated spot, 5=Oversaturated spot). The change in grade from Day 0 to Day 28 will be the primary outcome.Timepoint: Time points for outcome assessment in the present study are as follows: Baseline (Day 0): Assessment of facial sebum secretion using the blotting paper method and self-perceived oiliness using Visual Analogue Scale (VAS), prior to initiation of intervention. End of Intervention 4 Weeks (Day 28): Re-assessment of facial sebum secretion and VAS scores to evaluate the effect of the interventions. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sayed Tauleha Tabassum Tayyeb Bukhari
Z.V.M. Unani Medical College and Hospital, Pune
Outcome results
None listed